Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in Russia

RecruitingOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Severe Asthma
Trial Locations (15)

Unknown

NOT_YET_RECRUITING

Research Site, Kaliningrad

NOT_YET_RECRUITING

Research Site, Kemerovo

RECRUITING

Research Site, Krasnodar

RECRUITING

Research Site, Moscow

RECRUITING

Research Site, Nal'chik

RECRUITING

Research Site, Nizhny Novgorod

RECRUITING

Research Site, Novosibirsk

RECRUITING

Research Site, Orenburg

RECRUITING

Research Site, Petrozavodsk

RECRUITING

Research Site, Saint Petersburg

RECRUITING

Research Site, Shelehov

RECRUITING

Research Site, Stavropol

RECRUITING

Research Site, Tomsk

RECRUITING

Research Site, Ulan-Ude

RECRUITING

Research Site, Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY